Cargando…

Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients

Diastolic heart failure (DHF) is characterized by symptoms including reduced ventricular relaxation and compliance, resulting in congestion of pulmonary and systemic circulation. The curative effects of regular cardiac agents are ineffective. Thus, new agents are required to treat chronic cardiac fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHEN, ZHI-HAO, JIANG, YU-RONG, PENG, JIA-QIN, DING, JIA-WANG, LI, SONG, YANG, JIAN, WU, HUI, YANG, JUN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774326/ https://www.ncbi.nlm.nih.gov/pubmed/26998008 http://dx.doi.org/10.3892/etm.2015.2967

Ejemplares similares

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)

The effect of spironolactone on diastolic function in haemodialysis patients
por: Hauser, T., et al.
Publicado: (2021)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials
por: Li, Shuai, et al.
Publicado: (2018)

Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection
por: Sager, Rana, et al.
Publicado: (2020)

Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs
por: Adin, Darcy, et al.
Publicado: (2021)

Use, tolerability and compliance of spironolactone in the treatment of heart failure
por: Lachaine, Jean, et al.
Publicado: (2011)

‘Door-to-furosemide’ timing: early treatment of heart failure
por: Piazza, Vito
Publicado: (2019)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
por: Coffman, Melissa, et al.
Publicado: (2021)

Association between dosing of spironolactone and outcomes in heart failure with preserved ejection fraction patients combined with chronic kidney disease------Balance of efficacy and risk
por: Li, Jun-Feng, et al.
Publicado: (2023)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Effects of low-dose furosemide combined with aminophylline on the renal function in septic shock patients
por: Mai, Zhenhua, et al.
Publicado: (2023)

Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial
por: Gao, Yibing, et al.
Publicado: (2021)

Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose–Response Curves in Worsening Refractory Congestive Heart Failure
por: Paterna, Salvatore, et al.
Publicado: (2015)

Dose of furosemide before admission predicts diuretic efficiency and long‐term prognosis in acute heart failure
por: Blázquez‐Bermejo, Zorba, et al.
Publicado: (2021)

A new paradigm for the treatment of volume overload in heart failure-combined effect of tolvaptan with furosemide
por: Okamoto, Hiroshi
Publicado: (2013)

Effect of Hypertonic Saline Solution Combined with Furosemide on Acute Heart Failure: A Meta-Analysis
por: Li, Zuoqing, et al.
Publicado: (2022)

Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute Decompensated Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2015)

Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment
por: Choy, Manting, et al.
Publicado: (2022)

The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure
por: Shi, Jinzheng, et al.
Publicado: (2022)

Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study
por: Zhou, Hui‐min, et al.
Publicado: (2022)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
por: Ahmed, Fozia Z., et al.
Publicado: (2021)

Proteomic differences among patients with heart failure taking furosemide or torsemide
por: Cooper, Lauren B., et al.
Publicado: (2022)

The pathophysiology of diastolic heart failure
por: Phan, Thanh Trung, et al.
Publicado: (2010)

Diastolic Function in Heart Failure
por: Kovács, Sándor J
Publicado: (2015)

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
por: Herrera-Leaño, Nancy, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
por: Bounthavong, Mark, et al.
Publicado: (2018)

The Utilization of Spironolactone in Heart Failure Patients at a Tertiary Hospital in Saudi Arabia
por: Alotaibi, Abdulmalik S, et al.
Publicado: (2020)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution
por: Sica, Domenic A., et al.
Publicado: (2018)

Association of early administration of furosemide with improved oxygenation in patients with acute heart failure
por: Mikami, Takafumi, et al.
Publicado: (2021)

Echocardiographic evaluation of diastolic heart failure
por: Lo, Queenie, et al.
Publicado: (2015)

Hospital Variation of Spironolactone Use in Patients Hospitalized for Heart Failure in China—The China PEACE Retrospective Heart Failure Study
por: Yu, Yuan, et al.
Publicado: (2022)

A retrospective study on the short-term effect of high-dose spironolactone (80 mg/d) on chronic congestive heart failure
por: Tao, Pan, et al.
Publicado: (2021)

Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects
por: Galderisi, Maurizio
Publicado: (2005)

Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
por: Enzan, Nobuyuki, et al.
Publicado: (2020)

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives
por: Manolis, Antonis A, et al.
Publicado: (2019)

Comparison of Different Furosemide Regimens in the Treatment of Acute Heart Failure: A Meta-Analysis
por: Huang, Youpan, et al.
Publicado: (2022)

Furosemide‐induced haemolytic anaemia in an extreme elderly patient
por: Ho, I‐Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cvf1kof3h7rhmkqmk7men2s0sb